Dona Fleishaker

1.3k citations
28 papers · 939 · 3 hit papers · h-index 14

Impact in

    • Spondyloarthritis Studies and Treatments
    • Rheumatoid Arthritis Research and Therapies
    • Systemic Lupus Erythematosus Research
  • Hematology top 5%
    • Autoimmune and Inflammatory Disorders Research

Papers in

    • Spondyloarthritis Studies and Treatments 16
    • Rheumatoid Arthritis Research and Therapies 9
    • Autoimmune and Inflammatory Disorders Research 6

Dona Fleishaker

27 papers receiving 923 citations

Dona Fleishaker's Hit Papers

Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19 2024 · 58 citations
580+3+6Years since publication50100150200250

Peers

Dona Fleishaker
Comparison fields: 5 of 74
  • Rheumatology 585
  • Hematology 179
  • Immunology 231
  • Microbiology 6
  • Infectious Diseases 115
Replace Alejandro Souto with:
Alejandro Souto Spain
Juan Carlos Gómez de la Torre Peru
M. Tarallo Italy
Gérard Pivert France
Remy A. Pollock Canada
Sandrine Benoit Germany
Pierre Suchon France
Joris Schonkeren Netherlands
Pieter Meyer South Africa
Bach‐Nga Pham France
Dona Fleishaker relative to Alejandro Souto Spain Alejandro Souto's profile →
Citations per field
00.5×
Alejandro Souto · 1×
Citations per year

Countries citing papers authored by Dona Fleishaker

Since Specialization
Citations

This map shows the geographic impact of Dona Fleishaker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dona Fleishaker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dona Fleishaker more than expected).

Fields of papers citing papers by Dona Fleishaker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dona Fleishaker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dona Fleishaker. The network helps show where Dona Fleishaker may publish in the future.

Co-authors

The 25 scholars most cited alongside Dona Fleishaker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Dona Fleishaker Line = papers co-authored together Dona Fleishaker links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Tofacitinib in patients with ankylosing spondylitis: a phase II, 16-week, randomised, placebo-controlled, dose-ranging study
Hit paper breakdown →
2017275
2
Tofacitinib for the treatment of ankylosing spondylitis: a phase III, randomised, double-blind, placebo-controlled study
Hit paper breakdown →
2021165
3
Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19
Hit paper breakdown →
202458
4 200357
5 201251
6 202048
7 200348
8 201845
9 201632
10 202230
11 202129
12 201723
13 202015
14 202313
15 201712
16 20189
17 20236
18 20234
19 20174
20
Tofacitinib in Patients with Ankylosing Spondylitis: A Phase 2, 16-Week, Randomized, Placebo-Controlled, Dose-Ranging Study
20153

About Dona Fleishaker

Dona Fleishaker is a scholar working on Rheumatology, Hematology, Infectious Diseases, Pediatrics, Perinatology and Child Health and Immunology, having authored 28 papers that have together received 939 indexed citations. Recurring topics across this work include Spondyloarthritis Studies and Treatments (16 papers), Rheumatoid Arthritis Research and Therapies (9 papers), Autoimmune and Inflammatory Disorders Research (6 papers), Pharmaceutical studies and practices (3 papers), Antimicrobial Resistance in Staphylococcus (2 papers), Inflammatory mediators and NSAID effects (2 papers), Psoriasis: Treatment and Pathogenesis (2 papers) and Pharmacogenetics and Drug Metabolism (1 paper). The work is most often cited by research in Rheumatology (585 citations), Hematology (179 citations), Immunology (231 citations), Microbiology (6 citations) and Infectious Diseases (115 citations). Dona Fleishaker has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Keith S. Kanik, Sujatha Menon, Désirée van der Heijde, Atul Deodhar, Thijs Hendrikx, James Cheng‐Chung Wei, Edit Drescher, David Li, Lara Fallon and Cunshan Wang. Their work appears in journals such as Annals of the Rheumatic Diseases, Rheumatology and Therapy, Arthritis Research & Therapy, The Lancet Rheumatology and The Pediatric Infectious Disease Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact